U.S. markets closed

Scopus BioPharma Inc. (SCPS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.2400-0.1200 (-2.75%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
Total Revenue
0
0
0
0
Operating Expense
19,947
10,156
2,690
685.964
Operating Income
-19,947
-10,156
-2,690
-685.964
Net Non Operating Interest Income Expense
-1,284
-706.446
-
-
Pretax Income
-21,245
-10,862
-2,690
-685.964
Net Income Common Stockholders
-21,245
-10,862
-2,690
-685.964
Diluted NI Available to Com Stockholders
-21,245
-10,862
-2,690
-685.964
Basic EPS
-
-0.81
-0.18
-0.05
Diluted EPS
-
-0.81
-0.18
-0.05
Basic Average Shares
-
13,363
14,976
14,976
Diluted Average Shares
-
13,363
14,976
14,976
Total Operating Income as Reported
-19,947
-10,156
-
-
Total Expenses
19,947
10,156
2,690
685.964
Net Income from Continuing & Discontinued Operation
-21,245
-10,862
-2,690
-685.964
Normalized Income
-21,231
-10,862
-2,690
-685.964
Interest Expense
1,284
706.446
-
-
Net Interest Income
-1,284
-706.446
-
-
EBIT
-19,961
-10,156
-2,690
-685.964
EBITDA
-19,960
-
-
-
Reconciled Depreciation
1.501
1.44
0.664
-
Net Income from Continuing Operation Net Minority Interest
-21,245
-10,862
-2,690
-685.964
Total Unusual Items Excluding Goodwill
-14.274
-
-
-
Total Unusual Items
-14.274
-
-
-
Normalized EBITDA
-19,946
-10,154
-2,689
-685.964
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0